CENTOGENE NV

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CENTOGENE NV and buy or sell other stocks, ETFs, and their options commission-free!

About CNTGF

Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. 

CEO
David Jiménez
CEODavid Jiménez
Employees
493
Employees493
Headquarters
Rostock, Mecklenburg-Vorpommern
HeadquartersRostock, Mecklenburg-Vorpommern
Founded
2018
Founded2018
Employees
493
Employees493

CNTGF Key Statistics

Market cap
4.21M
Market cap4.21M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
3.28K
Average volume3.28K
High today
$0.145
High today$0.145
Low today
$0.145
Low today$0.145
Open price
$0.145
Open price$0.145
Volume
1.50K
Volume1.50K
52 Week high
$0.5501
52 Week high$0.5501
52 Week low
$0.0376
52 Week low$0.0376

People also own

Based on the portfolios of people who own CNTGF. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.